In agreement with this, when overexpressed, CBF maintains histone H3 hypoacetylated, hypomethylated on lysine 4 and hypermethylated on lysine 9, on MyoD target promoters, along with HDAC1 recruitment, even in differentiation conditions. homologous heterodimeric transcription factors named Core Binding Factors or CBF (examined in:[1]). In addition to the Runx1 subunit which binds DNA directly, CBF is composed of a non-DNA-binding subunit named CBFbeta (CBF)[2]. Runx1 binds better DNA in the presence of CBF.Runx1was Rabbit Polyclonal to RRAGA/B originally recognized at a breakpoint on human chromosome 21 in the t(8;21) translocation, known as the most common target of chromosomal translocations in human leukemia[3],[4]. Genetic studies showed that Runx1 is essential in the developing murine embryo for definitive hematopoiesis of all lineages[5],[6]. There is now strong evidence that Runx proteins are also important for differentiation of multiple cell types, including osteoblasts[7], neurons[8],[9], hematopoietic cells of all lineages[5],[6],[10]and skin epidermis and hair follicle stem cells[11],[12]. Runx1 is also involved in promoting senescence in main mouse fibroblasts[13], and in cell cycle regulation[14][16]. Runx proteins have the potential to either activate or repress transcription in a context dependent manner. Runx1 seems to promote proliferation in progenitor cells, whereas in differentiating cells it cooperates with tissue-specific transcription factors to regulate tissue-specific gene expression. For example, Runx1 cooperates with C/EBP and C/EBP to regulate hematopoiesis and osteogenesis, respectively[17],[18]. The dual role of Runx1 in regulating proliferation and differentiation could depend on differential interactions with protein partners, specific for each stage of cell development. The molecular mechanisms underlying such a switch in Runx1 function remain however to be deciphered. Runx1 and CBF have also been linked to skeletal muscle mass differentiation[19][21], and prevention of muscle losing[20]. In skeletal muscle mass, proliferation and differentiation are mutually unique. Indeed, skeletal muscle mass terminal differentiation begins with an irreversible withdrawal from your cell cycle, followed by muscle-specific marker expression[22]. Irreversible cell cycle exit entails a definitive silencing of proliferation-associated genes (examined in[23]and recommendations therein). Terminal muscle mass differentiation is usually orchestrated by myogenic bHLH transcription factors, such as MyoD and Myf5, two grasp myogenic determination factors. MyoD is expressed in proliferating myoblasts, but is unable to p-Synephrine activate its target genes even when bound to their promoters[24],[25]. MyoD therefore may have a repressive role at its target genes prior to initiating chromatin remodeling in differentiating cells[24],[26],[27]. In proliferating myoblasts, MyoD is usually associated with histone deacetylases (HDACs), the histone methyltransferase Suv39h1 and heterochromatin protein HP1, and might actively inhibit expression of its target genes by inducing a local repressive chromatin structure[24],[28],[29]. Here we show that CBF associates with MyoD preferentially in proliferating myoblasts, and knockdown of Runx1 or CBF accelerates cell cycle exit and terminal differentiation. Conversely, overexpression of CBF slows cell cycle exit and delays muscle mass differentiation. In proliferating myoblasts, the MyoD/CBF complex contains several chromatin modifying enzymes such as HDACs. In agreement with this, when overexpressed, CBF p-Synephrine maintains histone H3 hypoacetylated, hypomethylated on lysine 4 and hypermethylated on lysine 9, on MyoD target p-Synephrine promoters, along with HDAC1 recruitment, even in differentiation conditions. Finally, Runx1 is usually recruited to MyoD target genes preferentially in proliferating myoblasts, when these genes are repressed. Altogether, our data suggest that CBF transcription factor plays a pivotal role as a negative regulator of skeletal muscle mass terminal differentiation. == Results == == CBF Subunits, Runx1 and CBF, Interact with MyoD in Proliferating Myoblasts == In an attempt to characterize MyoD protein partners, we carried out double-affinity purification of HA-Flag MyoD stably expressed in HeLa cells (observe purification plan onFigure S1). MyoD protein complex composition was then analyzed by mass spectrometry (MS) and western blot (WB). MS analysis of the purified protein complex revealed some already known partners of MyoD (Physique S2), such as Id, Pbx1, PC4 and E12/E47, and partners that had by no means been explained to interact with MyoD. Indeed, MS analysis unveiled CBF protein within MyoD complex with a high quantity of peptides, covering almost 20% of its protein mass and amino acids content (Physique 1A). WB analyses confirmed that result and showed that Runx1 also co-purified with MyoD (Physique 1B). == Physique 1. Runx1 and CBF interact with MyoDin.